Roflumilast for eosinophilic chronic obstructive pulmonary disease?
- PMID: 30224320
- DOI: 10.1016/S2213-2600(18)30365-5
Roflumilast for eosinophilic chronic obstructive pulmonary disease?
Comment on
-
Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial.Lancet Respir Med. 2018 Nov;6(11):827-836. doi: 10.1016/S2213-2600(18)30331-X. Epub 2018 Sep 14. Lancet Respir Med. 2018. PMID: 30224319 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical